Impact of Carboplatin on Long-Term Survival after Neoadjuvant Chemotherapy in Non-Metastatic Triple-Negative Breast Cancer: An Algerian Cohort Study
Background: Triple-negative breast cancer (TNBC) is an aggressive subtype lacking estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expression. Platinum agents such as carboplatin have been incorporated into neoadjuvant regimens to improve pathological complete response (pCR)...